Brevan Howard Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 52,418 shares of BBIO stock, worth $3.48 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,418
Previous 104,110
49.65%
Holding current value
$3.48 Million
Previous $4.5 Million
39.44%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
445Shares Held
184MCall Options Held
11.3MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Viking Global Investors LP16MShares$1.06 Billion2.36% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$880 Million27.71% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$826 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X08.74MShares$580 Million0.22% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...